1. Home
  2. ADPT vs UVSP Comparison

ADPT vs UVSP Comparison

Compare ADPT & UVSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADPT
  • UVSP
  • Stock Information
  • Founded
  • ADPT 2009
  • UVSP 1876
  • Country
  • ADPT United States
  • UVSP United States
  • Employees
  • ADPT N/A
  • UVSP N/A
  • Industry
  • ADPT Biotechnology: Biological Products (No Diagnostic Substances)
  • UVSP Major Banks
  • Sector
  • ADPT Health Care
  • UVSP Finance
  • Exchange
  • ADPT Nasdaq
  • UVSP Nasdaq
  • Market Cap
  • ADPT 1.1B
  • UVSP 881.8M
  • IPO Year
  • ADPT 2019
  • UVSP 1989
  • Fundamental
  • Price
  • ADPT $9.03
  • UVSP $30.27
  • Analyst Decision
  • ADPT Buy
  • UVSP Hold
  • Analyst Count
  • ADPT 6
  • UVSP 3
  • Target Price
  • ADPT $9.83
  • UVSP $29.00
  • AVG Volume (30 Days)
  • ADPT 3.0M
  • UVSP 123.7K
  • Earning Date
  • ADPT 05-01-2025
  • UVSP 04-23-2025
  • Dividend Yield
  • ADPT N/A
  • UVSP 2.91%
  • EPS Growth
  • ADPT N/A
  • UVSP 11.32
  • EPS
  • ADPT N/A
  • UVSP 2.66
  • Revenue
  • ADPT $189,527,000.00
  • UVSP $294,306,000.00
  • Revenue This Year
  • ADPT $21.20
  • UVSP $8.70
  • Revenue Next Year
  • ADPT $21.99
  • UVSP $6.05
  • P/E Ratio
  • ADPT N/A
  • UVSP $11.37
  • Revenue Growth
  • ADPT 8.61
  • UVSP 2.88
  • 52 Week Low
  • ADPT $2.99
  • UVSP $20.37
  • 52 Week High
  • ADPT $10.28
  • UVSP $32.75
  • Technical
  • Relative Strength Index (RSI)
  • ADPT 57.82
  • UVSP 60.80
  • Support Level
  • ADPT $8.38
  • UVSP $29.93
  • Resistance Level
  • ADPT $9.51
  • UVSP $30.87
  • Average True Range (ATR)
  • ADPT 0.66
  • UVSP 0.84
  • MACD
  • ADPT 0.16
  • UVSP 0.21
  • Stochastic Oscillator
  • ADPT 63.02
  • UVSP 83.52

About ADPT Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

Share on Social Networks: